Manuel Praga

23.0k total citations · 3 hit papers
330 papers, 10.7k citations indexed

About

Manuel Praga is a scholar working on Nephrology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Manuel Praga has authored 330 papers receiving a total of 10.7k indexed citations (citations by other indexed papers that have themselves been cited), including 185 papers in Nephrology, 70 papers in Pulmonary and Respiratory Medicine and 53 papers in Surgery. Recurrent topics in Manuel Praga's work include Renal Diseases and Glomerulopathies (141 papers), Renal Transplantation Outcomes and Treatments (52 papers) and Chronic Kidney Disease and Diabetes (42 papers). Manuel Praga is often cited by papers focused on Renal Diseases and Glomerulopathies (141 papers), Renal Transplantation Outcomes and Treatments (52 papers) and Chronic Kidney Disease and Diabetes (42 papers). Manuel Praga collaborates with scholars based in Spain, United States and Italy. Manuel Praga's co-authors include Enrique Morales, Ester González, Eduardo Gutiérrez, Eduardo Hernández, Amado Andrés, José L. Rodicio, Luís M. Ruilope, Esteban Porrini, Aiko P. J. de Vries and Miguel Ayala León and has published in prestigious journals such as Science, The Lancet and SHILAP Revista de lepidopterología.

In The Last Decade

Manuel Praga

310 papers receiving 10.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Paracellin-1, a Renal Tight Junction Protein Required for Paracellular Mg ²⁺ Resorption

1999 819 citations Manuel Praga et al. profile →
Obesity-related glomerulopathy: clinical and pathologic characteristics and pathogenesis

2016 500 citations Vivette D. D’Agati, Aiko P. J. de Vries et al. profile →
Fatty kidney: emerging role of ectopic lipid in obesity-related renal disease

2014 376 citations Aiko P. J. de Vries, Piero Ruggenenti et al. The Lancet Diabetes & Endocrinology profile →

Peers

Countries citing papers authored by Manuel Praga

Since Specialization

Citations

This map shows the geographic impact of Manuel Praga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manuel Praga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manuel Praga more than expected).

Fields of papers citing papers by Manuel Praga

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manuel Praga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manuel Praga. The network helps show where Manuel Praga may publish in the future.

Co-authorship network of co-authors of Manuel Praga

This figure shows the co-authorship network connecting the top 25 collaborators of Manuel Praga. A scholar is included among the top collaborators of Manuel Praga based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manuel Praga. Manuel Praga is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Comparative Analysis of Proteinuria and Longitudinal Outcomes in Immune Complex Membranoproliferative Glomerulonephritis and C3 Glomerulopathy 2025 ·Kidney International Reports ·Fernando Caravaca‐Fontán, (unknown), Ana Huerta, (unknown), Patricia Martínez‐Miguel, Rosa Miquel, (unknown), Úrsula Verdalles, (unknown), (unknown), Carmen Mon, Gema Fernández‐Juárez, Manuel Praga, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	4
2	Predicting Remission in Antiphospholipase A2 Receptor Antibody-Associated Membranous Nephropathy 2025 ·Clinical Journal of the American Society of Nephrology ·Sean J. Barbour, (unknown), Manuel Praga, Fernando Caravaca‐Fontán, (unknown), (unknown), Hanna Dêbiec, Gema Fernández‐Juárez, Daniel C. Cattran, (unknown)	2
3	Severe hypertension with thrombotic microangiopathy: the need for pathogenically targeted treatments 2025 ·Kidney International ·Manuel Praga, Fernando Caravaca‐Fontán, Teresa Cavero, Gema Fernández‐Juárez, Eduardo Gutiérrez, Elena Goicoechea de Jorge	0
4	Antiproteinuric effect of SGLT2 inhibitors in non-diabetic glomerulopathies is dependent on body mass index 2025 ·Nephrology Dialysis Transplantation ·Maria J. Vargas-Brochero, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Marco Allinovi, Chiara Somma, Valentina Raglianti, (unknown), Ladan Zand, Sara Núñez, María José Soler, Sanjeev Sethi, Eduardo Gutiérrez, Manuel Praga, Fernando Caravaca‐Fontán, Paola Romagnani, Fernando C. Fervenza	1
5	Ten tips on immunosuppression in primary membranous nephropathy 2024 ·Clinical Kidney Journal ·Hernando Trujillo, Fernando Caravaca‐Fontán, Manuel Praga	6
6	#277 Update to the long-term safety and efficacy of iptacopan in C3G: 33-month extension study data from patients enrolled in a phase 2 study 2024 ·Nephrology Dialysis Transplantation ·Carla Nester, Ute Eisenberger, Alexandre Karras, Moglie Le Quintrec, Liz Lightstone, Manuel Praga, Giuseppe Remuzzi, María José Soler Romeo, Junhao Liu, Matthias Meier, Nicholas J.A. Webb, Edwin Wong	0
7	Diagnosis and treatment of lupus nephritis: a summary of the Consensus Document of the Spanish Group for the Study of Glomerular Diseases (GLOSEN) 2023 ·Clinical Kidney Journal ·Jorge Rojas-Rivera, Clara García-Carro, (unknown), M. Espino Hernández, Mario Espinosa, Gema Fernández‐Juárez, Xavier Fulladosa, Marián Goicoechea, Manuel Macı́a, Enrique Morales, Luís F. Quintana, Manuel Praga	13
8	Complement alternative pathway determines disease susceptibility and severity in antineutrophil cytoplasmic antibody (ANCA)–associated vasculitis 2023 ·Kidney International ·(unknown), Gema Fernández‐Juárez, (unknown), (unknown), (unknown), Teresa Cavero, (unknown), Juliana Draibe, (unknown), Fernando Caravaca‐Fontán, Manuel Praga, (unknown), Elena Goicoechea de Jorge	12
9	Targeting complement in IgA nephropathy 2023 ·Clinical Kidney Journal ·Fernando Caravaca‐Fontán, Eduardo Gutiérrez, Ángel Sevillano, Manuel Praga	29
10	Factor H–Related Protein 1 Drives Disease Susceptibility and Prognosis in C3 Glomerulopathy 2022 ·Journal of the American Society of Nephrology ·(unknown), (unknown), Agustín Tortajada, (unknown), Fernando Caravaca‐Fontán, Talat H. Malik, (unknown), Sandra Elías, Ana Sáiz, Gema Fernández‐Juárez, Pilar Sánchez‐Corral, Matthew C. Pickering, Manuel Praga, Santiago Rodrı́guez de Córdoba, Elena Goicoechea de Jorge	22
11	Variations in Circulating Active MMP-9 Levels during Renal Replacement Therapy 2020 ·Biomolecules ·Elena Rodríguez‐Sánchez, José Alberto Navarro‐García, (unknown), (unknown), (unknown), Teresa Bada-Bosch, Eduardo Hernández, (unknown), Amado Andrés, Manuel Praga, Mario Fernández‐Ruiz, José María Aguado, J. Segura, Luís M. Ruilope, Gema Ruiz‐Hurtado	6
12	Oxidative Status before and after Renal Replacement Therapy: Differences between Conventional High Flux Hemodialysis and on-Line Hemodiafiltration 2019 ·Nutrients ·José Alberto Navarro‐García, Elena Rodríguez‐Sánchez, (unknown), (unknown), (unknown), Laura González‐Lafuente, Teresa Bada-Bosch, Eduardo Hernández, (unknown), Manuel Praga, Luís M. Ruilope, Gema Ruiz‐Hurtado	20
13	Remission of Hematuria Improves Renal Survival in IgA Nephropathy 2017 ·Journal of the American Society of Nephrology ·Ángel Sevillano, Eduardo Gutiérrez, Claudia Yuste, Teresa Cavero, Evangelina Mérida, Paola Rodrı́guez, Ana García Álvarez, Enrique Morales, Cristina Fernández, Miguel Ángel Martínez, Juan Antonio Moreno, Manuel Praga	105
14	Síndrome nefrótico secundario a glomerulonefritis membranosa asociada al tratamiento con litio. 2017 ·SHILAP Revista de lepidopterología ·Mario Fernández‐Ruiz, (unknown), (unknown), Manuel Praga	0
15	Fatty kidney: emerging role of ectopic lipid in obesity-related renal disease breakdown → 2014 ·The Lancet Diabetes & Endocrinology ·Aiko P. J. de Vries, Piero Ruggenenti, Xiong Z. Ruan, Manuel Praga, Josep M. Cruzado, Ingeborg M. Bajema, Vivette D. D’Agati, Hildo J. Lamb, Draženka Pongrac Barlovič, Radovan Hojs, Manuela Abbate, (unknown), Carl Erik Mogensen, Esteban Porrini	376
16	Long-Term Outcomes of IgA Nephropathy Presenting with Minimal or No Proteinuria 2012 ·Journal of the American Society of Nephrology ·Eduardo Gutiérrez, I. Zamora, José Ballarín, Yolanda Arce, Sara Jiménez, C. Quereda, Teresa Olea, Jorge Martínez-Ara, Alfons Segarra, Carmen Bernis, (unknown), Marián Goicoechea, Soledad García de Vinuesa, Jorge Rojas-Rivera, Manuel Praga	137
17	Unilateral pleural effusions associated with stenoses of left brachiocephalic veins in haemodialysis patients 2005 ·Nephrology Dialysis Transplantation ·(unknown), Eduardo Gutiérrez, (unknown), Eduardo Hernández, José María Morillas Alcázar, Juan Carlos Herrero, Manuel Praga	5
18	Hemodialysis for Treatment of Accidental Hypothermia 1993 ·The Nephron journals/Nephron journals ·(unknown), Manuel Praga, José María Morillas Alcázar, José Morales, Juan Carlos Montejo, María José Jimenez, J.L. Rodicio	25
19	Long-Term Beneficial Effects of Angiotensin-Converting Enzyme Inhibition in Patients With Nephrotic Proteinuria 1992 ·American Journal of Kidney Diseases ·Manuel Praga, Eduardo Hernández, (unknown), Amado Andrés, Luís M. Ruilope, José L. Rodicio	104
20	Acute renal failure induced by oral acyclovir. 1991 ·PubMed ·(unknown), Manuel Praga, Fernando de Álvaro Moreno, (unknown)	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact